Mitochondrially targeted antioxidants and thiol reagents

Free Radical Biology and Medicine

Volumn 28, Issue 10, 2000, Pages 1547-1554

  Coulter, Carolyn V ^a   Kelso, Geoffrey F ^a   Lin, Tsu Kung ^a   Smith, Robin A J ^a   Murphy, Michael P ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Antioxidants; Free radicals; Mitochondria; Protein thiols

Indexed keywords

FREE RADICAL; OUTER MEMBRANE PROTEIN; THIOL DERIVATIVE;

CELL DAMAGE; CONFERENCE PAPER; DRUG MECHANISM; DRUG TARGETING; HUMAN; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CATIONS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MYOPATHIES; SULFHYDRYL REAGENTS;

EID: 0034656840     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00255-0     Document Type: Conference Paper

References (95)

1. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:1979;527-605.
2. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78:1998;547-581.
3. Shigenaga M.K., Hagen T.M., Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. USA. 91:1994;19771-19778.
4. Wallace D.C. Mitochondrial diseases in man and mouse. Science. 283:1999;1482-1488.
5. Lenaz G. Role of mitochondria in oxidative stress and aging. Biochim. Biophys. Acta. 1366:1998;53-67.
6. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite implications for endothelial injury from nitric oxide and superoxide . Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
7. Murphy M.P., Packer M.A., Scarlett J.L., Martin S.W. Peroxynitrite a biologically significant oxidant . Gen. Pharmacol. 31:1998;179-186.
8. Richter C., Park J.-W., Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. USA. 85:1988;6465-6467.
9. Ames B.N., Shigenaga M.K., Hagen T.M. Mitochondrial decay in aging. Biochim. Biophys. Acta. 1271:1995;165-170.
10. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 90:1993;7915-7922.
11. Lucas D.T., Szweda L.I. Cardiac reperfusion injury aging, lipid peroxidation, and mitochondrial dysfunction . Proc. Natl. Acad. Sci. USA. 95:1998;510-514.
12. Li Y., Huang T.-T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11:1995;376-381.
13. Lebovitz R.M., Zhang H., Vogel H., Cartwright J., Dionne L., Lu N., Huang S., Matzuk M.M. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. USA. 93:1996;9782-9787.
14. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., Wilcox H.M., Flood D.G., Beal M.F., Brown R.H., Scott R.W., Snider W.D. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13:1996;43-47.
15. Vercesi A.E., Castilho R.F., Meincke A.R., Valle V.G.R., Hermes-Lima M., Bechera E.J.H. Oxidative damage of mitochondria induced by 5-aminolevulinic acid role of Ca and membrane protein thiols . Biochim. Biophys. Acta. 1188:1994;86-92.
16. Petronilli V., Costantini P., Scorrano L., Colonna R., Passamonti S., Bernardi P. The voltage sensor of the mitochondrial permeability transition is tuned by the oxidation-reduction state of vicinal thiols. J. Biol. Chem. 269:1994;16638-16642.
17. Halestrap A.P., Woodfield K.-Y., Connern C.P. Oxidative stress, thiol reagents and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide carrier. J. Biol. Chem. 272:1997;3346-3354.
18. Butler A.R., Flitney F.W., Williams D.L.H. NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron nitrosyls in biology a chemist's perspective . Trends Pharmacol. Sci. 16:1995;18-22.
19. Reed D. Glutathione toxicological implications . Annu. Rev. Pharmacol. Toxicol. 30:1990;603-631.
20. Burns R.J., Smith R.A.J., Murphy M.P. Synthesis and characterization of thiobutyltriphenylphosphonium bromide, a novel thiol reagent targeted to the mitochondrial matrix. Arch. Biochem. Biophys. 322:1995;60-68.
21. Scarlett J.L., Packer M.A., Porteous C.M., Murphy M.P. Alterations to glutathione and nicotinamide nucleotides during the mitochondrial permeability transition induced by peroxynitrite. Biochem. Pharmacol. 52:1996;1047-1055.
22. Stamler J.S. Redox signaling nitrosylation and related target interactions of nitric oxide . Cell. 78:1994;931-936.
23. Stamler J.S., Hausladen A. Oxidative modifications in nitrosative stress. Nat. Struct. Biol. 5:1998;247-249.
24. Gavrikova E.V., Vinogradov A.D. Active/de-active state transition of the mitochondrial complex I as revealed by specific sulfhydryl group labeling. FEBS Lett. 455:1999;36-40.
25. Kroemer G., Zamzami N., Susin S.A. Mitochondrial control of apoptosis. Immunol. Today. 18:1997;44-51.
26. Goossens V., Grooten J., De Vos K., Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA. 92:1995;8115-8119.
27. Hennet T., Richter C., Peterhans E. Tumor necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cell. Biochem. J. 289:1993;587-592.
28. Levrat C., Larrick J.W., Wright S.C. Tumor necrosis factor induces activation of mitochondrial succinate dehydrogenase. Life Sci. 49:1991;1731-1737.
29. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacob W.A., Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267:1992;5317-5323.
30. Brand M.D. Measurement of mitochondrial proton motive force. Brown G.C., Cooper C.E. Bioenergetics - a practical approach. 1995;39-62 IRL, Oxford, UK.
31. Azzone G.F., Pietrobon D., Zoratti M. Determination of the proton electrochemical gradient across biological membranes. Curr. Top. Bioenergetics. 13:1984;1-77.
32. Chen L.B. Mitochondrial membrane potential in living cells. Annu. Rev. Cell Biol. 4:1988;155-181.
33. Murphy M.P. Targeting bioactive compounds to mitochondria. Trends Biotechnol. 15:1997;326-330.
34. Murphy M.P., Smith R.A.J. Drug delivery to mitochondria the key to mitochondrial medicine . Adv. Drug Deliv. Rev. 41:2000;235-250.
35. Rottenberg J. The measurement of membrane potential and pH gradient in cells, organelles and vesicles. Methods Enzymol. 55:1979;547-569.
36. Liberman E.A., Topali V.P., Tsofina L.M., Jasaitis A.A., Skulachev V.P. Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature. 222:1969;1076-1078.
37. Smith J.C. Potential-sensitive probes in membranes of bioenergetic relevance. Biochim. Biophys. Acta. 1016:1990;1-28.
38. Berry M.N., Edwards A.M., Barrit G.J., Grivell M.B., Halls H.J., Gannon B.J., Friend D.S. Isolated hepatocytes preparation, properties and applications . Burdon R.H., van Knippenberg P.H. Laboratory techniques in biochemistry and molecular biology. vol. 21:1991;386-390 Elsevier, Amsterdam.
39. Burns R.J., Murphy M.P. Labeling of mitochondrial proteins in living cells by the thiol probe thiobutyltriphenylphosphonium bromide. Arch. Biochem. Biophys. 339:1997;33-39.
40. Smith R.A.J., Porteous C.M., Coulter C.V., Murphy M.P. Targeting an antioxidant to mitochondria. Eur. J. Biochem. 263:1999;709-716.
41. Rideout D.C., Calogeropoulou T., Jaworski J.S., Dagnino R., McCarthy M.R. Phosphonium salts exhibiting selective anti-carcinoma activity in vitro. Anticancer Drug Des. 4:1989;265-280.
42. Nocentini S., Moreno G., Petit P.X., Guggiari M., Salet C., Demerseman P., Dodin G. Induction of mitochondrial dysfunction and apoptosis in HeLa cells by bispyridinium oximes, a newly synthesized family of lipophilic biscations. Biochem. Pharmacol. 53:1997;1543-1552.
43. Teicher B.A., Holden S.A., Cathcart K.N.S. Efficacy of Pt(Rh-123)2 as a radiosensitizer with fractioned X rays. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;1217-1224.
44. Manetta G., Nasseeri A., Podnos Y.D., Emma D., Dorion G., Rawlings L., Carpenter P.M., Bustamante A., Patel J., Rideout D. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Gynecol. Oncol. 60:1996;203-212.
45. Patel J., Rideout D., McCarthy M.R., Calogeropoulou T., Wadwa K.S., Oseroff A.R. Antineoplastic activity, synergism and antagonism of trialkylphosphonium salts and their combinations. Anticancer Res. 14:1994;21-28.
46. Rideout D., Bustamante A., Patel J. Mechanism of inhibition of FaDu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride. Int. J. Cancer. 57:1994;247-253.
47. Rideout D. Self assembling drugs a new approach to biochemical modulation in cancer chemotherapy . Cancer Invest. 12:1994;189-202.
48. Matthews R.T., Yang L., Browne S., Bail M., Beal M.F. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc. Natl. Acad. Sci. USA. 95:1998;8892-8897.
49. Miquel J., Ferraniz M.L., De Juan E., Sevilla I., Martinez M. N-acetylcysteine protects against age-related decline of oxidative phosphorylation in liver mitochondria. Eur. J. Pharmacol. 292:1995;333-335.
50. Sokol R.J., McKim J.M., Goff M.C., Ruyle S.Z., Devereaux M.W., Han D., Packer L., Everson G. Vitamin E reduces oxidant injury to mitochondria and the hepatoxicity of taurochenodeoxycholic acid in the rat. Gastroenterology. 114:1998;164-174.
51. Melov S., Schneider J.A., Day B.J., Hinerfeld D., Coskun P., Mira S.S., Crapo J.D., Wallace D.C. A novel neurological phenotype in mice lacking manganese superoxide dismutase. Nat. Genet. 18:1998;159-163.
52. Halliwell B.H., Gutteridge J.M.C. Free radicals in biology and medicine. 1989;Oxford University Press, Oxford, UK.
53. Dugan L.L., Turetsky D.M., Du C., Lobner D., Wheeler M., Almi C.R., Shen C.K.-F., Luh T.-Y., Choi D.W., Lin T.-S. Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. USA. 94:1997;9434-9439.
54. Krusic P.J., Wasserman E., Keizer P.N., Mortin J.R., Preston K.F. Radical reactions of C60. Science. 254:1991;1183-1185.
55. Gitler C., Zarmi B., Kalef E. General methods to identify and enrich vicinal thiol proteins present in intact cells in the oxidized disulfide state. Anal. Biochem. 252:1997;48-55.
56. Schagger H. Native electrophoresis for isolation of mitochondrial oxidative phosphorylation complexes. Methods Enzymol. 260:1995;190-202.
57. Bernardi P.E. Mitochondria in cell death [special issue]. Biochim. Biophys. Acta. 1366:1998;1-234.
58. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
59. Kroemer G., Dallaporta B., Resche-Rignon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60:1998;619-642.
60. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.-I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2 release of cytochrome c from mitochondria blocked . Science. 275:1997;1129-1132.
61. Kluck R.M., Martin S.J., Hoffman B.M., Zhou J.S., Green D.R., Newmeyer D.D. Cytochrome c activation of CPP32-like proteolysis plays a critical role in Xenopus cell-free apoptosis system. EMBO J. 16:1997;4639-4649.
62. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria a primary site for Bcl-2 regulation of apoptosis . Science. 275:1997;1132-1136.
63. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441-446.
64. Li P., Nijhawan I., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
65. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:1997;405-413.
66. Vander Heiden M.G., Chandel N.S., Schumacker P.T., Thompson C.B. Bcl-Xl prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol. Cell. 3:1999;159-167.
67. Vander Heiden M.G., Chandel N.S., Williamson E.K., Schumacker P.T., Thompson C.B. Bcl-xl regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:1997;627-637.
68. Samali A., Cai J., Zhivotovsky B., Jones D.P., Orrenius S. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp-60 and Hsp 10 in the mitochondrial fraction of Jurkat cells. EMBO J. 18:1999;2040-2048.
69. Reed J.C., Jurgensmeier J., Matsuyama S. Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta. 1366:1998;127-137.
70. Susin S.A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1996;1-11.
71. Hockenberry E.A. Bcl-2, a novel regulator of cell death. Bioessays. 17:1995;631-638.
72. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
73. Marzo I., Brenner C., Zamzami N., Jurgensmeier J.M., Susin S.A., Vieira H.L.A., Prevost M.-C., Xie Z., Matsuyama S., Reed J.C., Kroemer G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 281:1998;2027-2031.
74. Wang H.-G., Pathan N., Ethell I.M., Krajewski S., Yamaguchi Y., Shibasaki F., McKeon F., Bobo T., Franke T.F., Reed J.C. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science. 284:1999;339-343.
75. Scarlett J.L., Murphy M.P. Release of apoptogenic proteins from the mitochondrial intermembrane space during the mitochondrial permeability transition. FEBS Lett. 418:1997;282-286.
76. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53 induced apoptosis. Nature. 389:1997;300-305.
77. Zoratti M., Zabo I. The mitochondrial permeability transition. Biochim. Biophys. Acta. 1241:1995;139-176.
78. Halestrap A.P., Kerr P.M., Javadov S., Woodfield K.Y. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury. Biochim. Biophys. Acta. 1366:1998;79-94.
79. Lemasters J.J., Nieminen A.-L., Qian T., Trost L.C., Elmore S.P., Nishimura Y., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A., Herman B. The mitochondrial permeability transition in cell death a common mechanism in necrosis, apoptosis and autophagy . Biochim. Biophys. Acta. 1366:1998;177-196.
80. Kroemer G., Petit P., Zamami N., Vayssiere J.-L., Mignotte B. The biochemistry of programmed cell death. FASEB J. 9:1995;1277-1287.
81. Ichas F., Jouaville L.S., Mazat J.-P. Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell. 89:1997;1145-1153.
82. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;2239-2244.
83. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis a basic biological phenomenon with wide ranging implications in tissue kinetics . Br. J. Cancer. 26:1972;239-257.
84. Hale A.J., Smith C.A., Sutherland L.C., Stoneman V.E.A., Longthorne V.L., Culhane A.C., Williams G.T. Apoptosis molecular regulation of cell death . Eur. J. Biochem. 236:1996;1-26.
85. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death the significance of apoptosis . Int. Rev. Cytol. 68:1980;251-306.
86. Nicotera P., Bellomo G., Orrenius S. Calcium-mediated mechanisms in chemically induced cell death. Annu. Rev. Pharmacol. Toxicol. 32:1992;449-470.
87. Fagian M.M., Pereira-da-Silva L., Martins I.S., Vercesi A.E. Membrane protein thiol cross-linking associated with the permeabilization of the inner mitochondrial membrane by Ca plus prooxidants. J. Biol. Chem. 265:1990;19955-19960.
88. Murphy M.P. Nitric oxide and cell death. Biochim. Biophys. Acta. 1411:1999;401-414.
89. Mohr S., Stamler J.S., Brune B. Mechanism of covalent modification of glyceraldehyde-3-phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite and related nitrosating agents. FEBS Lett. 348:1994;223-227.
90. Ghafourifar P., Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett. 418:1997;291-296.
91. Tatoyan A., Giulivi C. Purification and characterization of a nitric-oxide synthase from rat liver mitochondria. J. Biol. Chem. 273:1998;11044-11048.
92. Melov S., Coskun P., Patel M., Tuinstra R., Cottrell B., Jun A.S., Zastawny T.H., Dizdaroglu M., Goodman S.I., Huang T.T., Miziorko H., Epstein C.J., Wallace D.C. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. USA. 96:1999;846-851.
93. Williams M.D., Van Remmen H., Conrad C.G., Huang T.-T., Epstein C.J., Richardson A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem. 273:1998;28510-28515.
94. Price D.L., Sisodia S.S., Borchelt D.R. Genetic neurodegenerative diseases the human illness and transgenic models . Science. 282:1998;1079-1083.
95. Odagiri Y., Uchida H., Hosokawa M., Takemoto K., Morley A.A., Takeda T. Accelerated accumulation of somatic mutations in the senesence accelerated mouse. Nat. Genet. 19:1998;116-117.